| scholarly article | Q13442814 |
| P50 | author | Eva Hernando | Q40230064 |
| Chao Cheng | Q87770555 | ||
| P2093 | author name string | Christopher I Amos | |
| Ronglai Shen | |||
| Nancy E Thomas | |||
| Marianne Berwick | |||
| Mary Jo Turk | |||
| Yanding Zhao | |||
| Ivan P Gorlov | |||
| Evelien Schaafsma | |||
| P2860 | cites work | Advances in immunotherapy for melanoma | Q26768558 |
| Global cancer statistics, 2012 | Q27860501 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts | Q28728722 | ||
| Genetic basis for clinical response to CTLA-4 blockade in melanoma | Q29620594 | ||
| Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma | Q30422102 | ||
| Inferring tumour purity and stromal and immune cell admixture from expression data | Q30674996 | ||
| Melanoma: tumor microenvironment and new treatments | Q33675676 | ||
| Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system | Q34086787 | ||
| Translating tumor antigens into cancer vaccines | Q34484042 | ||
| Genomic Classification of Cutaneous Melanoma | Q34670776 | ||
| Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy. | Q35828560 | ||
| Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma | Q36730827 | ||
| Molecular and genetic properties of tumors associated with local immune cytolytic activity | Q36869059 | ||
| Comprehensive analyses of tumor immunity: implications for cancer immunotherapy | Q37193493 | ||
| Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study | Q37289626 | ||
| Genomic correlates of response to CTLA-4 blockade in metastatic melanoma | Q37319470 | ||
| Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases | Q37375070 | ||
| Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival | Q37453537 | ||
| MAGE A3 antigen-specific cancer immunotherapeutic | Q37773275 | ||
| Therapeutic vaccines for cancer: an overview of clinical trials | Q38227030 | ||
| Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma | Q38394496 | ||
| Type I interferons in anticancer immunity | Q38509280 | ||
| An immunogenic personal neoantigen vaccine for patients with melanoma | Q38692859 | ||
| Targeted agents and immunotherapies: optimizing outcomes in melanoma | Q38856722 | ||
| Mutational Landscape and Sensitivity to Immune Checkpoint Blockers | Q38889870 | ||
| Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment. | Q38996594 | ||
| Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. | Q39011183 | ||
| CDK4/6 inhibition triggers anti-tumour immunity. | Q40081387 | ||
| A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring | Q40262319 | ||
| HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer | Q41431266 | ||
| Human Tumor Antigens and Cancer Immunotherapy | Q41533232 | ||
| Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients. | Q43627503 | ||
| Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information. | Q44133547 | ||
| Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. | Q45949028 | ||
| The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. | Q46373510 | ||
| Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma | Q47157659 | ||
| A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma | Q47590835 | ||
| Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients | Q48252817 | ||
| Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome | Q48661799 | ||
| A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival | Q49525456 | ||
| Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. | Q50954469 | ||
| Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy. | Q50965911 | ||
| A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations. | Q52582134 | ||
| Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. | Q55036914 | ||
| Melanoma | Q57571848 | ||
| Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment | Q59275946 | ||
| Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response | Q70918943 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 109-119 | |
| P577 | publication date | 2018-08-31 | |
| P1433 | published in | Molecular Cancer Research | Q2751014 |
| P1476 | title | A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis | |
| P478 | volume | 17 |
| Q89884092 | Decreasing Microtubule Actin Cross-Linking Factor 1 Inhibits Melanoma Metastasis by Decreasing Epithelial to Mesenchymal Transition |
| Q92746202 | Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis |
| Q91759638 | Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases |
Search more.